Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
Novo Nordisk bets $600M biobucks on NanoVation's ability to take genetic medicines beyond the liver
Fierce Biotech
Wed, 09/18/24 - 01:23 pm
Novo Nordisk
NanoVation Therapeutics
biobucks
genetic medicine
US Senator Sanders says generic drugmakers could sell Ozempic for less than $100/month
Reuters
Tue, 09/17/24 - 11:11 pm
Bernie Sanders
generics
Novo Nordisk
drug pricing
Ozempic
Obesity pill race heats up as Novo, Roche and Terns share data
BioSpace
Tue, 09/17/24 - 11:22 am
obesity
Novo Nordisk
Roche
Terns Pharmaceuticals
amycretin
TERN-601
CT-996
clinical trials
Novo Nordisk hails ‘remarkable’ weight loss result for dual-acting oral drug in early trial
Fierce Biotech
Wed, 09/11/24 - 11:53 am
Novo Nordisk
obesity
clinical trials
amycretin
Study backs role of Novo Nordisk obesity drug in children
Pharmaphorum
Wed, 09/11/24 - 11:36 am
Novo Nordisk
pediatrics
obesity
clinical trials
Saxenda
Weight-loss market to see 16 new drugs by 2029, report estimates
Reuters
Tue, 09/10/24 - 04:29 pm
weight loss
obesity
Amgen
Pfizer
Roche
Novo Nordisk
Eli Lilly
Boehinger Ingelheim
Structure Therapeutics
Viking Therapeutics
Zealand Pharma
Altimmune
57 Million Eligible For GLP-1 Drug Coverage In U.S. And That’s Just Those Under 65
Forbes
Thu, 09/5/24 - 10:29 pm
obesity
GLP-1
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
insurers
New research could ease concerns over suicide risk of obesity drugs
BioPharma Dive
Tue, 09/3/24 - 05:58 pm
obesity
suicide
GLP-1
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
Zepbound
Novo Nordisk's Ozempic shortage expected to continue into Q4
Reuters
Mon, 09/2/24 - 12:19 pm
Novo Nordisk
Ozempic
drug shortages
Novo builds heart failure case for semaglutide
BioPharma Dive
Fri, 08/30/24 - 11:31 am
Novo Nordisk
obesity
semaglutide
cardiovascular disease
Medicare Coverage of Novo’s Semaglutide for CVD Could Cost $145B Annually: Study
BioSpace
Tue, 08/27/24 - 11:32 am
Novo Nordisk
cardiovascular disease
Medicare
semaglutide
Wegovy
Ozempic
Ozempic on Wall Street's list for 2027 Medicare drug negotiations
Reuters
Fri, 08/23/24 - 10:59 am
Ozempic
Novo Nordisk
Pfizer
GSK
Medicare
drug pricing
Does Ozempic increase the risk of suicidal thoughts? A new study muddles the picture
Stat
Tue, 08/20/24 - 11:11 am
Novo Nordisk
Ozempic
Wegovy
suicidal ideation
Novo Nordisk to build $220 mln raw materials plant in Denmark
Reuters
Fri, 08/16/24 - 11:20 am
Novo Nordisk
Novo Nordisk Pharmatech
Denmark
drug manufacturing
IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Medicare
drug pricing
Inflation Reduction Act
JNJ
Xarelto
Imbruvica
Stelara
Bristol Myers Squibb
Eliquis
Eli Lilly
Jardiance
Merck
Januvia
Amgen
Enbrel
AstraZeneca
Farxiga
Novo Nordisk
Fiasp
Novartis
Entresto
Doctors struggle to get Wegovy for older Americans with heart disease
Reuters
Thu, 08/15/24 - 11:41 am
Novo Nordisk
Medicare
Wegovy
physicians
weight loss
5 Obesity Readouts to Watch in the Second Half of 2024
BioSpace
Tue, 08/13/24 - 11:47 am
obesity
clinical trials
Novo Nordisk
CagriSema
Amgen
MariTide
Monlunabant
Aphaia Pharma
APHD-012
Terns Pharmaceuticals
TERN-601
Novo Nordisk plots 2024 FDA filing for once-weekly insulin and semaglutide combo
Fierce Pharma
Mon, 08/12/24 - 06:01 pm
Novo Nordisk
FDA
insulin
semaglutide
Icosema
Weight-loss drugs like Wegovy may help stave off some cancers
NPR
Mon, 08/12/24 - 11:28 am
cancer
GLP-1 agonist
Wegovy
Zepbound
Novo Nordisk
Eli Lilly
Pharma execs react to final drug price negotiations with Medicare
Pharma Voice
Fri, 08/9/24 - 11:21 am
Medicare
drug pricing
Inflation Reduction Act
Bristol Myers Squibb
Eli Lilly
JNJ
Bayer
Merck
AstraZeneca
Novartis
Amgen
AbbVie
Novo Nordisk
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »